Favipiravir tablet
Form: Tablet
Strength: 200 mg, 400 mg, 600 mg
Reference Brands: Fabiflu, Favicovid, Covihalt, Avifavir, Avigan, Favira , Favilow(Globally, Not approved in USA & EU)
Category: Anti Covid Medicines
Favipiravir is a broad-spectrum antiviral used in the treatment of mild to moderate COVID-19 in countries like India, Japan, Russia, and Bangladesh. Commonly available in 200 mg and 400 mg tablets, it is marketed under leading brands such as Fabiflu, Avigan, and Avifavir. While not approved in the US or EU, Favipiravir remains in demand across Asia, the Middle East, and Latin America. Global PharmaB2B platforms connect verified Favipiravir suppliers, manufacturers, and exporters, ensuring regulatory-compliant sourcing, competitive pricing, and bulk availability. Partner with trusted B2B pharmaceutical networks for efficient distribution and international trade.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Baricitinib
Strength: 2 mg, 4 mg
Form: Tablet
Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)
View Details Get Enquiry
Nirmatrelvir + Ritonavir
Strength: Nirmatrelvir(150 mg) + Ritonavir(100 mg)
Form: Tablet
Reference Brands: Paxlovid®(US & EU- For Emergency Use Authorization)
View Details Get Enquiry
Tocilizumab
Strength: IV: 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL; SQ: 162 mg/0.9 mL (pen or syringe)
Form: IV injection, SQ Injection
Reference Brands: Actemra®(US); RoActemra®(EU)
View Details Get Enquiry
Molnupiravir
Strength: 200 mg
Form: Oral capsule
Reference Brands: Lagevrio®(Us & EU)
View Details Get Enquiry